gemini-2.5-flash-preview-09-2025| input-price: 0.3 output-price: 2.5 max-context-length: 128_000 (cost: $0.005) Β· Anfrage: 2025-10-20T03:29:13.260073

Generated by rs-summarizer Version unbekannt

Abstract:

This short educational segment addresses a persistent nomenclature problem in dermatopathology concerning the classification of certain nerve sheath tumors. The speaker advocates for the term "nerve sheath myxoma" (NSM), describing it as a multi-nodular, hypocellular myxoid proliferation of the nerve sheath, which is invariably S100 positive and likely represents a variant of schwannoma. The core confusion arises because NSM (previously called conventional/myxoid neurothekeoma) shares a similar name with "cellular neurothekeoma." The speaker emphasizes the critical distinction: cellular neurothekeoma is S100 negative, non-neural, and a fundamentally different entity, despite the confusing historical terminology.

Nomenclature Confusion in Nerve Sheath Tumors: Nerve Sheath Myxoma vs. Cellular Neurothekeoma

Summary Rating: No ratings yet
Article Rating: No ratings yet

Source